Lipoprotein(a) Levels in Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation Compared to Controls
Median Lp(a) levels were only mildly higher in severe AS patients undergoing TAVI in comparison to a large control group, mainly driven by higher Lp(a) levels in males. Higher Lp(a) levels were not associated with an earlier age at TAVI, rejecting its association with an accelerated disease progression.
Authors
- Amir Halkin
- Arie Steinvil (ORCID: https://orcid.org/0000-0002-6070-4187)
- Jeremy Ben‐Shoshan (ORCID: https://orcid.org/0000-0002-0838-4358)
- Maayan Konigstein (ORCID: https://orcid.org/0000-0002-9398-471X)
- Itamar Loewenstein (ORCID: https://orcid.org/0000-0002-5550-5490)
- Ilana Goldiner
- Shmuel Banai (ORCID: https://orcid.org/0000-0002-3299-2839)
- Daniel A. Lichtenstein (ORCID: https://orcid.org/0000-0002-6923-1056)
- Ariel Finkelstein
- Yaron Arbel
Institutions
- Tel Aviv Sourasky Medical Center (IL)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101264
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Novartis